Verici Dx plc announced it has completed successful transfer of a portion of the Company's urine samples as announced as part of the global commercialisation and licensing agreement announced in November 2023. A s previously stated, it demonstrates the additional value in the Company's data and sample assets for research. Following completion of the transfer, full payment has been received.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.25 GBX | -3.85% |
|
-7.41% | -35.90% |
18/06 | EARNINGS AND TRADING: Cordel thrilled by Middle East contract win | AN |
18/06 | Verici Dx plc Announces Successful Transfer of Urine Samples to Thermo Fisher Scientific | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
550.8 USD | -1.32% | -1.15% | 21TCr | ||
6.25 GBX | -3.85% | -7.41% | 1.92Cr | ||
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.90% | 1.92Cr | |
-10.34% | 1.14TCr | |
-12.48% | 739.82Cr | |
+31.15% | 563.58Cr | |
+0.26% | 533.25Cr | |
-18.68% | 370.26Cr | |
+7.43% | 257.78Cr | |
-64.53% | 237.62Cr | |
+27.01% | 220.02Cr | |
-11.15% | 220.46Cr |
- Stock Market
- Equities
- VRCI Stock
- News Verici Dx plc
- Verici Dx plc Announces Successful Transfer of Urine Samples to Thermo Fisher Scientific